Boston, MA, June 17, 2016 --(PR.com
)-- This report analyzes the PCR Technologies global market in terms of market revenue ($ million) for all segments and it enables PCR product manufacturers, distributors and wholesalers, pharma & biotech companies, academics, Research institutes and contract manufacturers to identify and analyze market expansion opportunities, upcoming technologies, patent trends and competition in PCR technologies global market.
Polymerase Chain Reaction is a process in which multiple copies of desired DNA sequence is obtained in a short period of time. This technique involves three steps namely denaturation, annealing and extension which are repeated at every cycle to obtain the required gene amplification. PCR technology global market is advancing at a steady rate. As estimated by IQ4I Research, PCR technology global market expected to reach $15,421 million by 2022. Currently, PCR technology has its applications in clinical diagnostics, industrial applications, and biomedical research.
The factors driving the growth of this market are increasing demand for innovative technology supporting early and accurate diagnosis of life threatening disease, rising demand for PCR in genetic and molecular testing, expiry of key players PCR patents, rising investments in the field of companion diagnostics, advent of digital PCR, increasing RT-PCR based food safety testing, increasing affinity for automated high throughput and robotic systems and multiplexed analytical strategies for improving sensitivity and speed of PCR technology. However, few factors like high cost of commercial PCR assays in the clinical diagnostics, lack of awareness and requirement of skilled labour, and development of alternative technologies are hampering the market.
The PCR technologies global market by products is segmented into instruments, reagents and consumables and software. Reagents and consumables holds the largest market revenue grow at a highest CAGR followed by instruments. Instruments include traditional and real-time thermocyclers while reagents and consumables include enzymes, dNTP’s, template DNA, primers and probes, buffers, master mixes, nuclease free water and others (tracking dye and wax beads). Software in the PCR market comprises Primer designers and sequence software’s, PCR data analysis software and others.
By application, the market is segmented into clinical diagnostics, industrial applications, and others (Pathogen detection and dentistry). Clinical diagnostics are further divided into infectious and non-infectious diseases. Infectious disease includes hepatitis B & C, tuberculosis, HIV and others. Non-infectious diseases include prenatal diagnosis, tissue typing, cancer therapy, genetic typing for hereditary disease, blood screening and others. Industrial applications are divided into agricultural biotechnology, environmental, applied testing, animal husbandry and biomedical research. Applied testing includes forensic and food safety testing while biomedical research includes DNA sequencing, genotyping, biomarker discovery, gene expression and genetic mapping, DNA cloning and others. Among the applications, industrial applications of PCR holds the largest share. Clinical diagnostics is the fastest growing segment from 2015 to 2022. The latest application of PCR is seen in cell-free DNA technology which used in prenatal diagnosis of disorders.
By Technique, the PCR market is segmented into standard PCR, real-time PCR, reverse transcriptase PCR, digital PCR, assembly PCR, multiplex PCR, hot start PCR and others. Among the PCR techniques Real Time PCR/qPCR holds the largest share. Digital PCR (dPCR) is the fastest growing segment. The real-time PCR, nested PCR and digital PCR technique is used where the point mutations are analysed using qualitative real-time PCR by using specific allele probes to analyse the genetic disorder that the foetus has developed. Droplet digital PCR is one of the new and alternative technologies for qPCR for the quantification of DNA templates. The massive portioning of the sample is the main aspect of this technology making it unique from other PCR technologies.
The PCR end users are segmented into hospitals and laboratories, pharmaceuticals, CRO’s and biotech companies, academics and others (Blood banks). Among these Pharmaceuticals CRO’s and biotech companies are expected to grow strongly.
The PCR technology global market based on geography is divided into North America, Europe, Asia-Pacific and Rest of the world. North American region commanded the largest revenue.
Analytik Jena (Germany), Applied Biosystems (U.S.), Eppendorf AG (Germany), Agilent Technologies (U.S.), Auxilab S.L (Spain), Chai Biotechnology (U.S.), Biogenex (U.S.), DaAn gene (China), Seegene (South Korea), New England Biolabs Inc. (U.S.), Premier Biosoft (India), Diatherix (U.S.) and Bibby scientific limited (U.K.) are some of the emerging players in the PCR technologies market.
The major key players in the global PCR market include Abbott Laboratories, Inc., Inc. (U.S.), Agilent Technologies (U.S.), BioMerieux SA (France), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc. (U.S.), GE Healthcare (U.K.), Qiagen N.V. (The Netherlands), Promega Corporation (U.S.), Merck KGaA (Germany), Hoffman-La Roche (Switzerland), Takara Bio, Inc (Japan), and Thermo Fisher Scientific, Inc (U.S.).